Lingling Wu
- Molecular Biology
- Nephrology top 2%
- Immunology top 10%
- Epidemiology
- Pulmonary and Respiratory Medicine
- Topics
- Renal Diseases and Glomerulopathies (9 papers)Chronic Kidney Disease and Diabetes (7 papers)Renal and related cancers (7 papers)
- Journals
- PLoS ONEBiomaterialsCancer Research
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Lingling Wu
60 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 102
- Molecular Biology 468
- Nephrology 260
- Immunology 240
- Epidemiology 151
- Pulmonary and Respiratory Medicine 108
Countries citing papers authored by Lingling Wu
This map shows the geographic impact of Lingling Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingling Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingling Wu more than expected).
Fields of papers citing papers by Lingling Wu
This network shows the impact of papers produced by Lingling Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingling Wu. The network helps show where Lingling Wu may publish in the future.
Co-authorship network of co-authors of Lingling Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Lingling Wu. A scholar is included among the top collaborators of Lingling Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingling Wu. Lingling Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 22 | |
| 6 | 25 | |
| 7 | 4 | |
| 8 | 40 | |
| 9 | 16 | |
| 10 | 0 | |
| 11 | 9 | |
| 12 | 7 | |
| 13 | 4 | |
| 14 | 8 | |
| 15 | 18 | |
| 16 | 14 | |
| 17 | 19 | |
| 18 | 15 | |
| 19 | 27 | |
| 20 | SCH 727965, a novel cyclin-dependent kinase inhibitor, has potent anti-tumor acitivity in a wide-spectrum of human tumor xenograft models | 1 |
About Lingling Wu
Lingling Wu is a scholar working on Nephrology, Immunology and Hepatology, having authored 65 papers that have together received 1.2k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (9 papers), Chronic Kidney Disease and Diabetes (7 papers) and Renal and related cancers (7 papers). The work is most often cited by research in Nephrology (260 citations), Immunology (240 citations) and Molecular Biology (468 citations). Lingling Wu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Xiangmei Chen, Guangyan Cai, Quan Hong, Zhe Feng, Bo Fu, Shaoyuan Cui, Wen Cao, Chao Hu, Jie Gao and Xiaoniao Chen. Their work appears in journals such as PLoS ONE, Biomaterials and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.